New tablet program aims to curb teen suicide in rural ERs

NCT ID NCT07325474

First seen Jun 26, 2026 · Last updated Aug 05, 2026 · Updated 5 times

Summary

This study tests a tablet-based program called Plan & Protect for teens aged 12-17 who visit rural emergency departments with suicidal thoughts or self-harm. The program helps teens and their caregivers create a personalized safety plan and reduce access to firearms and medications at home. Researchers will compare outcomes for families who use the program to those who receive usual care, measuring changes in home safety and suicide risk over three months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Plan & Protect safety planning intervention (behavioral program)
What this could lead to
If successful, this could provide a practical, culturally sensitive tool to reduce suicide risk and improve home safety for at-risk teens in rural areas.
What could go wrong
This is an observational study, not a randomized trial, so results may be less definitive. The program's effectiveness may vary across different rural settings and populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SUICIDE ATTEMPT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Suicide Suicide, Attempted

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Alice Peck Day Memorial Hospital

    Lebanon, New Hampshire, 03766, United States

  • Cheshire Medical Center

    Keene, New Hampshire, 03431, United States

  • Dartmouth-Hitchcock Medical Center

    Lebanon, New Hampshire, 03756, United States

  • New London Hospital

    New London, New Hampshire, 03257, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.